{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:21:52Z","timestamp":1792660912885,"version":"4.5.0"},"reference-count":106,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T00:00:00Z","timestamp":1565654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The main objective of this review is to discuss recent advancements in the overall investigation and in vivo prediction of drug absorption. The intestinal permeability of an orally administered drug (given the value Peff) has been widely used to determine the rate and extent of the drug\u2019s intestinal absorption (Fabs) in humans. Preclinical gastrointestinal (GI) absorption models are currently in demand for the pharmaceutical development of novel dosage forms and new drug products. However, there is a strong need to improve our understanding of the interplay between pharmaceutical, biopharmaceutical, biochemical, and physiological factors when predicting Fabs and bioavailability. Currently, our knowledge of GI secretion, GI motility, and regional intestinal permeability, in both healthy subjects and patients with GI diseases, is limited by the relative inaccessibility of some intestinal segments of the human GI tract. In particular, our understanding of the complex and highly dynamic physiology of the region from the mid-jejunum to the sigmoid colon could be significantly improved. One approach to the assessment of intestinal permeability is to use animal models that allow these intestinal regions to be investigated in detail and then to compare the results with those from simple human permeability models such as cell cultures. Investigation of intestinal drug permeation processes is a crucial biopharmaceutical step in the development of oral pharmaceutical products. The determination of the intestinal Peff for a specific drug is dependent on the technique, model, and conditions applied, and is influenced by multiple interactions between the drug molecule and the biological membranes.<\/jats:p>","DOI":"10.3390\/pharmaceutics11080411","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T04:31:21Z","timestamp":1565670681000},"page":"411","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":234,"title":["Intestinal Permeability and Drug Absorption: Predictive Experimental, Computational and In Vivo Approaches"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5586-2906","authenticated-orcid":false,"given":"David","family":"Dahlgren","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Uppsala University, Box 580 SE-751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lennern\u00e4s","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Uppsala University, Box 580 SE-751 23 Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0009-9236(96)90208-8","article-title":"Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies","volume":"60","author":"Hellriegel","year":"1996","journal-title":"Clin. Pharm. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejps.2014.02.010","article-title":"In vivo methods for drug absorption\u2013comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation\/API\/excipient characterization including food effects","volume":"57","author":"Abrahamsson","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1021\/acs.molpharmaceut.6b00514","article-title":"Regional intestinal permeability of three model drugs in human","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0192623313505930","article-title":"The Colon From Banal to Brilliant","volume":"42","author":"Sellers","year":"2013","journal-title":"Toxicol. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/mp800261a","article-title":"Toward an increased understanding of the barriers to colonic drug absorption in humans: Implications for early controlled release candidate assessment","volume":"6","author":"Tannergren","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/acs.molpharmaceut.7b00279","article-title":"Regional intestinal permeability in rats: A comparison of methods","volume":"14","author":"Roos","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Heimbach, T., Suarez-Sharp, S., Kakhi, M., Holmstock, N., Olivares-Morales, A., Pepin, X., Sj\u00f6gren, E., Tsakalozou, E., Seo, P., and Li, M. (2019). Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link\u2014A Workshop Summary Report. ed., Springer.","DOI":"10.1208\/s12248-019-0298-x"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1021\/acs.molpharmaceut.6b00824","article-title":"In vivo predictive dissolution (IPD) and biopharmaceutical modeling and simulation: Future use of modern approaches and methodologies in a regulatory context","volume":"14","author":"Lennernas","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1080\/00498250701704819","article-title":"Intestinal permeability and its relevance for absorption and elimination","volume":"37","author":"Lennernas","year":"2007","journal-title":"Xenobiotica"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/03602530600952172","article-title":"What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs","volume":"39","author":"Roffey","year":"2007","journal-title":"Drug Metab. Rev."},{"key":"ref_12","unstructured":"Food, Drug and Administration (2000). Guidance for Industry: Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, Food Drug Administrain."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.bmc.2011.03.011","article-title":"QSAR-based permeability model for drug-like compounds","volume":"19","author":"Gozalbes","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.2174\/092986709789578213","article-title":"How to recognize and workaround pitfalls in QSAR studies: A critical review","volume":"16","author":"Scior","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/j.bbamem.2015.12.014","article-title":"Molecular simulation of nonfacilitated membrane permeation","volume":"1858","author":"Rowley","year":"2016","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.jcim.6b00022","article-title":"Simulation-based approaches for determining membrane permeability of small compounds","volume":"56","author":"Lee","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_17","unstructured":"Cyclic Peptide Design (2019). Design Principles for Intestinal Permeability of Cyclic Peptides, Springer."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ejps.2013.09.008","article-title":"PBPK models for the prediction of in vivo performance of oral dosage forms","volume":"57","author":"Kostewicz","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1517\/17425250902835506","article-title":"Introduction to computational oral absorption simulation","volume":"5","author":"Sugano","year":"2009","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1021\/acs.molpharmaceut.5b00861","article-title":"In silico modeling of gastrointestinal drug absorption: Predictive performance of three physiologically based absorption models","volume":"13","author":"Tannergren","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cpt.37","article-title":"Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective","volume":"97","author":"Jones","year":"2015","journal-title":"Clin. Pharm. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejps.2016.06.006","article-title":"Use of physiologically relevant biopharmaceutics tools within the pharmaceutical industry and in regulatory sciences: Where are we now and what are the gaps?","volume":"91","author":"Flanagan","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ejps.2016.10.036","article-title":"IMI\u2013oral biopharmaceutics tools project\u2013evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results","volume":"96","author":"Margolskee","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejps.2016.09.027","article-title":"IMI\u2013oral biopharmaceutics tools project\u2013evaluation of bottom-up PBPK prediction success part 1: Characterisation of the OrBiTo database of compounds","volume":"96","author":"Margolskee","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ejps.2016.09.037","article-title":"IMI\u2013Oral biopharmaceutics tools project\u2013Evaluation of bottom-up PBPK prediction success part 3: Identifying gaps in system parameters by analysing In Silico performance across different compound classes","volume":"96","author":"Darwich","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/psp4.33","article-title":"Application of physiologically based pharmacokinetic (PBPK) modeling to support dose selection: Report of an FDA public workshop on PBPK","volume":"4","author":"Wagner","year":"2015","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e13008","DOI":"10.1111\/nmo.13008","article-title":"Established and emerging methods for assessment of small and large intestinal motility","volume":"29","author":"Poulsen","year":"2017","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevBiomedEng.2014010846","article-title":"Ingestible gastrointestinal sampling devices: State-of-the-art and future directions","volume":"42","author":"Jones","year":"2014","journal-title":"Crit. Rev. \u2122 Biomed. Eng."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11095-017-2331-z","article-title":"Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat\u2014Biophysical Model and Predictions Based on Caco-2","volume":"35","author":"Zur","year":"2018","journal-title":"Pharm. Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1021\/acs.molpharmaceut.7b00353","article-title":"Preclinical effect of absorption modifying excipients on rat intestinal transport of five model compounds and the intestinal barrier marker 51Cr-EDTA","volume":"14","author":"Dahlgren","year":"2017","journal-title":"Mol. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1748-1716.2012.02411.x","article-title":"The selective cyclooxygenase-2 inhibitor parecoxib markedly improves the ability of the duodenum to regulate luminal hypertonicity in anaesthetized rats","volume":"205","author":"Sedin","year":"2012","journal-title":"Acta Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijpharm.2018.07.057","article-title":"Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport","volume":"549","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1748-1716.2010.02196.x","article-title":"The impact of cyclooxygenase inhibition on duodenal motility and mucosal alkaline secretion in anaesthetized rats","volume":"201","author":"Nylander","year":"2011","journal-title":"Acta Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejpb.2019.06.011","article-title":"Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model","volume":"142","author":"Dahlgren","year":"2019","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/mp500834v","article-title":"Human in vivo regional intestinal permeability: Quantitation using site-specific drug absorption data","volume":"12","author":"Dahlgren","year":"2015","journal-title":"Mol. Pharm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ijpharm.2018.05.029","article-title":"The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs","volume":"547","author":"Dahlgren","year":"2018","journal-title":"Int. J. Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/acs.molpharmaceut.6b00515","article-title":"Regional intestinal permeability in dogs: Biopharmaceutical aspects for development of oral modified-release dosage forms","volume":"13","author":"Dahlgren","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5056\/jnm18112","article-title":"Propagation Characteristics of Fasting Duodeno-Jejunal Contractions in Healthy Controls Measured by Clustered Closely-spaced Manometric Sensors","volume":"25","author":"Baker","year":"2019","journal-title":"J. Neurogastroenterol. Motil."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/cbdv.200900112","article-title":"In silico prediction of human oral absorption based on QSAR analyses of PAMPA permeability","volume":"6","author":"Akamatsu","year":"2009","journal-title":"Chem. Biodivers."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejps.2012.10.007","article-title":"Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique","volume":"48","author":"Lutz","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jps.2600790604","article-title":"Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorbtive (Caco-2) cells","volume":"79","author":"Artursson","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0168-3659(01)00427-8","article-title":"Dipeptide model prodrugs for the intestinal oligopeptide transporter. Affinity for and transport via hPepT1 in the human intestinal Caco-2 cell line","volume":"76","author":"Nielsen","year":"2001","journal-title":"J. Control. Release"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: Implications for drug\u2013drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharm. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1208\/s12248-013-9456-8","article-title":"Drug Discovery and Regulatory Considerations for Improving In Silico and In Vitro Predictions that Use Caco-2 as a Surrogate for Human Intestinal Permeability Measurements","volume":"15","author":"Larregieu","year":"2013","journal-title":"AAPS J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1208\/s12248-017-0178-1","article-title":"Intestinal stem cells to advance drug development, precision, and regenerative medicine: A paradigm shift in translational research","volume":"20","author":"Mochel","year":"2018","journal-title":"AAPS J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Chandra, L., Borcherding, D.C., Kingsbury, D., Atherly, T., Ambrosini, Y.M., Bourgois-Mochel, A., Yuan, W., Kimber, M., Qi, Y., and Wang, Q. (2019). Derivation of adult canine intestinal organoids for translational research in gastroenterology. BMC Biol., 17.","DOI":"10.1186\/s12915-019-0652-6"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.stem.2018.11.016","article-title":"Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition","volume":"23","author":"Fujii","year":"2018","journal-title":"Cell Stem Cell."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1126\/science.1234852","article-title":"Growing self-organizing mini-guts from a single intestinal stem cell: Mechanism and applications","volume":"340","author":"Sato","year":"2013","journal-title":"Science"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drudis.2012.11.008","article-title":"The promiscuous binding of pharmaceutical drugs and their transporter-mediated uptake into cells: What we (need to) know and how we can do so","volume":"18","author":"Kell","year":"2013","journal-title":"Drug Discov. Today"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.drudis.2011.05.010","article-title":"Pharmaceutical drug transport: The issues and the implications that it is essentially carrier-mediated only","volume":"16","author":"Kell","year":"2011","journal-title":"Drug Discov. Today."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrd3187","article-title":"Coexistence of passive and carrier-mediated processes in drug transport","volume":"9","author":"Sugano","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1021\/mp400713v","article-title":"Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition","volume":"11","author":"Smith","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1529\/biophysj.105.060871","article-title":"Permeation of aromatic carboxylic acids across lipid bilayers: The pH-partition hypothesis revisited","volume":"89","author":"Thomae","year":"2005","journal-title":"Biophys. J."},{"key":"ref_55","first-page":"435","article-title":"Effect of molecular charge on intestinal epithelial drug transport: pH-dependent transport of cationic drugs","volume":"291","author":"Palm","year":"1999","journal-title":"J. Pharm. Exp. Ther."},{"key":"ref_56","first-page":"2516","article-title":"pH dependent but not P-gp dependent bidirectional transport study of S-propranolol: The importance of passive diffusion","volume":"32","author":"Zheng","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1242\/jeb.144048","article-title":"Integrative physiology of transcellular and paracellular intestinal absorption","volume":"220","author":"Karasov","year":"2017","journal-title":"J. Exp. Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-201x.1999.00510.x","article-title":"Jejunal permeability in humans in vivo and rats in situ: Investigation of molecular size selectivity and solvent drag","volume":"165","author":"Fagerholm","year":"1999","journal-title":"Acta Physiol. Scand."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.semcdb.2015.04.008","article-title":"Conceptual barriers to understanding physical barriers","volume":"42","author":"Lingaraju","year":"2015","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"F1078","DOI":"10.1152\/ajprenal.00116.2003","article-title":"Reversal of charge selectivity in cation or anion-selective epithelial lines by expression of different claudins","volume":"285","author":"Fanning","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1086\/683114","article-title":"Intestinal water absorption varies with expected dietary water load among bats but does not drive paracellular nutrient absorption","volume":"88","author":"Price","year":"2015","journal-title":"Physiol. Biochem. Zool."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/physrev.00019.2012","article-title":"Claudins and the modulation of tight junction permeability","volume":"93","author":"Yu","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1021\/jm901846t","article-title":"How Well Can the Caco-2\/Madin\u2212 Darby Canine Kidney Models Predict Effective Human Jejunal Permeability?","volume":"53","author":"Avdeef","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/apt.13329","article-title":"Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: Influence of age, gender, study country and testing protocol","volume":"42","author":"Wang","year":"2015","journal-title":"Aliment. Pharm. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ijpharm.2004.02.010","article-title":"Permeation characteristics of a hydrophilic basic compound across a bio-mimetic artificial membrane","volume":"275","author":"Sugano","year":"2004","journal-title":"Int. J. Pharm."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2007.02.001","article-title":"Permeation of permanently positive charged molecules through artificial membranes\u2014Influence of physico-chemical properties","volume":"31","author":"Fischer","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2016.02.001","article-title":"When barriers ignore the \u201crule-of-five\u201d","volume":"101","author":"Aschmann","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbamem.2005.07.009","article-title":"Behaviour of small solutes and large drugs in a lipid bilayer from computer simulations","volume":"1718","author":"Bemporad","year":"2005","journal-title":"Biochim. Biophys. Acta (BBA) Biomembr."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.bpj.2013.12.027","article-title":"Ion-induced defect permeation of lipid membranes","volume":"106","author":"Vorobyov","year":"2014","journal-title":"Biophys. J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1038\/srep01949","article-title":"Defined lipid analogues induce transient channels to facilitate drug-membrane traversal and circumvent cancer therapy resistance","volume":"3","author":"Melo","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s002320001019","article-title":"Influence of a transmembrane protein on the permeability of small molecules across lipid membranes","volume":"173","author":"Xiang","year":"2000","journal-title":"J. Membr. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1021\/mp100050d","article-title":"Enabling the intestinal absorption of highly polar antiviral agents: Ion-pair facilitated membrane permeation of zanamivir heptyl ester and guanidino oseltamivir","volume":"7","author":"Miller","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1023\/A:1015963128124","article-title":"Ion pair transport across membranes","volume":"6","author":"Neubert","year":"1989","journal-title":"Pharm. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1021\/ja8081704","article-title":"Free energy for the permeation of Na+ and Cl\u2212 ions and their ion-pair through a zwitterionic dimyristoyl phosphatidylcholine lipid bilayer by umbrella integration with harmonic fourier beads","volume":"131","author":"Khavrutskii","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nchem.1243","article-title":"Quantifying the chemical beauty of drugs","volume":"4","author":"Bickerton","year":"2012","journal-title":"Nat. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1039\/c1md00093d","article-title":"Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space","volume":"2","author":"Alex","year":"2011","journal-title":"Med. Chem. Comm."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1021\/jm100087s","article-title":"Intramolecular hydrogen bonding in medicinal chemistry","volume":"53","author":"Kuhn","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1107\/S0108270100010349","article-title":"Tetracycline hydrochloride: A synchrotron microcrystal study","volume":"56","author":"Clegg","year":"2000","journal-title":"Acta Crystallogr. Sect. C Cryst. Struct. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1021\/acs.jpcb.7b02914","article-title":"Predicting a drug\u2019s membrane permeability: A computational model validated with in vitro permeability assay data","volume":"121","author":"Bennion","year":"2017","journal-title":"J. Phys. Chem. B."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1039\/c0sm00136h","article-title":"Permeability of drugs and hormones through a lipid bilayer: Insights from dual-resolution molecular dynamics","volume":"6","author":"Orsi","year":"2010","journal-title":"Soft Matter"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"290","DOI":"10.4103\/0975-1483.59315","article-title":"Microdosing vs. Therapeutic dosing for evaluation of pharmacokinetic data: A comparative study","volume":"1","author":"Mahajan","year":"2009","journal-title":"J. Young Pharm."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00271380","article-title":"Dose proportional absorption of 25\u2013150 mg atenolol","volume":"44","author":"Wakelkamp","year":"1993","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00609750","article-title":"Studies on the pharmacokinetics and pharmacodynamics of atenolol in man","volume":"13","author":"Fitzgerald","year":"1978","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1177\/0091270011408612","article-title":"Microdosing clinical study: Pharmacokinetic, pharmacogenomic (SLCO2B1), and interaction (grapefruit juice) profiles of celiprolol following the oral microdose and therapeutic dose","volume":"52","author":"Ieiri","year":"2012","journal-title":"J. Clin. Pharm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1002\/jps.21618","article-title":"Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol","volume":"98","author":"Kato","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/00498257809060955","article-title":"Disposition and metabolism of atenolol in animals","volume":"8","author":"Reeves","year":"1978","journal-title":"Xenobiotica"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00498257809060956","article-title":"Metabolism of atenolol in man","volume":"8","author":"Reeves","year":"1978","journal-title":"Xenobiotica"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpt1979254408","article-title":"Kinetics and absolute bioavailability of atenolol","volume":"25","author":"Mason","year":"1979","journal-title":"Clin. Pharm. Ther."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1124\/dmd.115.066175","article-title":"Atenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins","volume":"43","author":"Yin","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2125.2012.04324.x","article-title":"Apple juice greatly reduces systemic exposure to atenolol","volume":"75","author":"Jeon","year":"2013","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00228-005-0930-9","article-title":"Effects of orange juice on the pharmacokinetics of atenolol","volume":"61","author":"Lilja","year":"2005","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2010.03722.x","article-title":"Fruit juice inhibition of uptake transport: A new type of food\u2013drug interaction","volume":"70","author":"Bailey","year":"2010","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2125.1992.tb04105.x","article-title":"Effects of a non-absorbable osmotic load on drug absorption in healthy volunteers","volume":"34","author":"Riley","year":"1992","journal-title":"Br. J. Clin. Pharm."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jpba.2003.11.016","article-title":"HPLC with programmed wavelength fluorescence detection for the simultaneous determination of marker compounds of integrity and P-gp functionality in the Caco-2 intestinal absorption model","volume":"34","author":"Augustijns","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/acs.molpharmaceut.5b00874","article-title":"IPEC-J2 MDR1, a novel high-resistance cell line with functional expression of human P-glycoprotein (ABCB1) for drug screening studies","volume":"13","author":"Saaby","year":"2016","journal-title":"Mol. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ejps.2008.08.004","article-title":"Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories","volume":"35","author":"Hayeshi","year":"2008","journal-title":"Eur J. Pharm. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/1061186031000086117","article-title":"Drug absorption from the isolated perfused rat lung\u2013correlations with drug physicochemical properties and epithelial permeability","volume":"11","author":"Tronde","year":"2003","journal-title":"J. Drug Target."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1124\/dmd.109.026591","article-title":"Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice evaluation of a novel tool in biopharmaceutical drug profiling","volume":"37","author":"Mols","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/bdd.710","article-title":"Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling","volume":"31","author":"Brouwers","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.2042-7158.1996.tb05904.x","article-title":"Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier","volume":"48","author":"Terao","year":"1996","journal-title":"J. Pharm. Pharm."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-7843.2005.pto_223.x","article-title":"Effect of itraconazole on the pharmacokinetics of atenolol","volume":"97","author":"Lilja","year":"2005","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s11095-008-9555-x","article-title":"Microdosing assessment to evaluate pharmacokinetics and drug metabolism in rats using liquid chromatography-tandem mass spectrometry","volume":"25","author":"Ni","year":"2008","journal-title":"Pharm. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3109\/00365521.2014.898326","article-title":"Surface area of the digestive tract-revisited","volume":"49","author":"Helander","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF01061457","article-title":"The unit impulse response procedure for the pharmacokinetic evaluation of drug entry into the central nervous system","volume":"17","author":"Baljet","year":"1989","journal-title":"J. Pharm. Biopharm."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuint.2008.12.002","article-title":"A new blood\u2013brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes","volume":"54","author":"Nakagawa","year":"2009","journal-title":"Neurochem. Int."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12987-017-0078-x","article-title":"Revisiting atenolol as a low passive permeability marker","volume":"14","author":"Chen","year":"2017","journal-title":"Fluids Barriers CNS"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/8\/411\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:10:39Z","timestamp":1760188239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/8\/411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":106,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["pharmaceutics11080411"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics11080411","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,13]]}}}